EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
AstraZeneca FY2026 EPS Forecast Raised by Leerink Partnrs
AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by XML Financial LLC
True North Advisors LLC Acquires Shares of 4,544 AstraZeneca PLC (NASDAQ:AZN)
Wesbanco Bank Inc. Buys 26,391 Shares of AstraZeneca PLC (NASDAQ:AZN)
Koshinski Asset Management Inc. Has $454,000 Stock Position in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery By Investing.com
AstraZeneca to invest $570m in Canada, creating 700 new jobs By Investing.com
AstraZeneca PLC Sued for Securities Law Violations - Contact The Gross Law Firm Before February 21, 2025 to Discuss Your Rights - AZN | Morningstar
Merit Financial Group LLC Acquires 4,117 Shares of AstraZeneca PLC (NASDAQ:AZN)
Promoting pharma technology transfer with more policy support
Why Is AstraZeneca PLC (AZN) Among the Best Large-Cap Value Stocks to Buy in 2025?
Artificial Intelligence in Drug Discovery Market Report - Revenue to Reach from $1.71 Bn to $8.52 Bn by 2030 - Arizton
Analysts Issue Forecasts for AstraZeneca FY2026 Earnings
FY2026 EPS Estimates for AstraZeneca Increased by Analyst
AstraZeneca PLC (NASDAQ:AZN) Stock Holdings Decreased by Chesley Taft & Associates LLC
Atomi Financial Group Inc. Sells 9,128 Shares of AstraZeneca PLC (NASDAQ:AZN)
Chesley Taft & Associates LLC Lowers Holdings in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Lmcg Investments LLC
Perpetual Ltd Sells 19,416 Shares of AstraZeneca PLC (NASDAQ:AZN)
UMB Bank n.a. Acquires 4,153 Shares of AstraZeneca PLC (NASDAQ:AZN)
Diversify Advisory Services LLC Cuts Position in AstraZeneca PLC (NASDAQ:AZN)
Arkadios Wealth Advisors Sells 3,786 Shares of AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca's Strategic Positioning and Datroway Approval Drive Buy Rating Amidst Evolving Breast Cancer Treatment Landscape
ASTRAZENECA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against AstraZeneca PLC and Encourages Investors to Contact the Firm | Morningstar
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN | Morningstar
Nanotechnology Drug Delivery Market Expected To Reach USD 213.2 Billion by 2032, with a CAGR of 9.3% | AstraZeneca, Sanofi, Bausch Health Companies Inc. | Valuespectrum.com
Regulatory actions for Jan. 22, 2025 | BioWorld
Faruqi & Faruqi Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN By Investing.com
AstraZeneca PLC (NASDAQ:AZN) Holdings Lifted by Brookmont Capital Management
AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by ZWJ Investment Counsel Inc.
AstraZeneca (AZN) Gets a Buy from Goldman Sachs
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of "Buy" from Brokerages
Trinasolar Powers AstraZeneca's Sustainability Vision with Cutting-Edge Solar Carpark Rooftop Install | The Manila Times
AstraZeneca Faces Legal Challenges Amidst China Investigation
FDA approves Daiichi Sankyo's Trop-2 ADC for breast cancer | BioWorld
FDA Approves AstraZeneca, Daiichi Sankyo's Datroway for Previously Untreated Unresectable, Metastatic HR-Positive, HER2-Negative Breast Cancer
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by LVW Advisors LLC
AstraZeneca And Daiichi Sankyo's Datroway Gets US Approval For Metastatic HR+ Breast Cancer | Markets Insider
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Daiichi Sankyo rises most in five months on cancer drug approval - The Japan Times
AstraZeneca Secures FDA Nod for New ADC Drug Datroway in Breast Cancer - January 20, 2025 - Zacks.com
AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Veery Capital LLC
AstraZeneca's Fasenra set to revolutionise COPD treatment as Phase III data builds anticipation
AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug
Professional Advisory Services Inc. Raises Stake in AstraZeneca PLC (NASDAQ:AZN)
Procyon Advisors LLC Has $2.21 Million Stake in AstraZeneca PLC (NASDAQ:AZN)
23,847 Shares in AstraZeneca PLC (NASDAQ:AZN) Purchased by Empirical Asset Management LLC
FDA Okays AstraZeneca And Daiichi's Datroway For Metastatic HR-Positive, HER2-Negative Breast Cancer | Markets Insider
AstraZeneca PLC (NASDAQ:AZN) Short Interest Update
AstraZeneca's DATROWAY Receives FDA Approval for Advanced Breast Cancer Treatment
With COPD drug race nears finish line, AstraZeneca gearing to catch up GSK by presenting Phase 3 data
AstraZeneca's Datroway approved in U.S. for HER2-negative breast cancer patients
FDA Approves AstraZeneca's Calquence for Previously Untreated Mantle Cell Lymphoma
AstraZeneca PLC (AZN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit | Morningstar
Boston Common Asset Management LLC Has $28.26 Million Stake in AstraZeneca PLC (OTCMKTS:AZNCF)
Channel Wealth LLC Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Guggenheim lifts AstraZeneca stock target, buy rating on prospects By Investing.com
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma | Morningstar
AstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AZN | Morningstar
FDA approves AstraZeneca's Calquence for untreated mantle cell lymphoma By Investing.com
AstraZeneca's Calquence gains FDA nod for 1L MCL treatment By Investing.com
AstraZeneca gains on getting nod from CDSCO to import new drug Eculizumab | Capital Market News - Business Standard
FDA approves new MCL treatment by AstraZeneca By Investing.com
AstraZeneca Pharma share price rises 3% on CDSCO nod for Eculizumab | News on Markets - Business Standard
AstraZeneca's rare disease portfolio gets a boost as company prepares to launch blockbuster drug in India
Kepler Capital Remains a Hold on AstraZeneca (AZN)
Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales - January 17, 2025 - Zacks.com
Calquence Plus Chemoimmunotherapy Approved in the U.S. for Patients with Previously Untreated Mantle Cell Lymphoma
ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN By Investing.com
Park Avenue Securities LLC Acquires 14,711 Shares of AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (NASDAQ:AZN) Stock Position Reduced by Assenagon Asset Management S.A.
Pines Wealth Management LLC Invests $378,000 in AstraZeneca PLC (NASDAQ:AZN)
Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles
Cellectis files to sell 44M ordinary shares for holders
Cox Capital Mgt LLC Grows Position in AstraZeneca PLC (NASDAQ:AZN)
Community Trust & Investment Co. Acquires 8,903 Shares of AstraZeneca PLC (NASDAQ:AZN)
Short Interest in AstraZeneca PLC (OTCMKTS:AZNCF) Expands By 116.7%
SpringWorks Therapeutics' SWOT analysis: biotech stock shows promise amid challenges By Investing.com
Is AstraZeneca (AZN) Top Stock Pick in Billionaire George Soros' Portfolio?
Trade Tracker: Jim Lebenthal buys Astrazeneca
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN By Investing.com
Tlwm Has $1.09 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Miracle Mile Advisors LLC Boosts Position in AstraZeneca PLC (NASDAQ:AZN)
Nordea Investment Management AB Acquires New Holdings in AstraZeneca PLC (NASDAQ:AZN)
Latest news
Stock market today: Most Asian stocks fell after US equities declined
MicroStrategy joins Nasdaq-100 index: MSTR stock performance analysis 2024
Morning Note: Tesla Soars, AUDUSD Hits Key Support, Oil & SP500 Insights
Nikkei 225 up 1.39%: Japanese Stocks Rise Following Yen's Continued Weakness
